Literature DB >> 22942502

Obstructive sleep apnea affects hospital outcomes of patients with non-ST-elevation acute coronary syndromes.

Luis C L Correia1, Alexandre C Souza, Guilherme Garcia, Michael Sabino, Mariana Brito, Mayara Maraux, Márcia M N Rabelo, J Péricles Esteves.   

Abstract

STUDY
OBJECTIVE: We aimed to test the hypothesis that clinically suspected obstructive sleep apnea (OSA) independently predicts worse in-hospital outcome in patients with non-ST elevation acute coronary syndromes.
DESIGN: At admission, individuals were evaluated for clinical probability of OSA by the Berlin Questionnaire. Primary cardiovascular endpoint was defined as the composite of death, nonfatal myocardial infarction, or refractory angina during hospitalization.
SETTING: Coronary care unit. PATIENTS: There were 168 consecutive patients admitted with unstable angina or non-ST elevation acute myocardial infarction. MEASUREMENTS AND
RESULTS: During a median hospitalization of 8 days, the incidence of cardiovascular events was 13% (12 deaths, 4 nonfatal myocardial infarctions, and 6 refractory anginas.) Incidence of the primary endpoint was 18% in individuals with high probability of OSA, compared with no events in individuals with low probability (P = 0.002). After logistic regression adjustment for the Global Registry of Acute Coronary Events (GRACE) risk score, anatomic severity of coronary disease, and hospital treatment, probability of OSA remained an independent predictor of events (odds ratio [OR] = 3.4; 95% confidence interval [CI] = 1.3 - 9.0; P = 0.015). Prognostic discrimination of the GRACE score, measured by a C-statistic of 0.72 (95% CI = 0.59-0.85), was significantly improved to 0.82 (95% CI = 0.73-0.92) after inclusion of OSA probability in the predictive model (P = 0.03).
CONCLUSION: Considering the independent prognostic and incremental value of suspected OSA, this condition may represent an aggravating factor for patients with non-ST elevation acute coronary syndrome.

Entities:  

Keywords:  Acute coronary syndromes; myocardial infarction; obstructive sleep apnea; prognosis; unstable angina

Mesh:

Year:  2012        PMID: 22942502      PMCID: PMC3413801          DOI: 10.5665/sleep.2078

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  24 in total

1.  Suspicion of obstructive sleep apnea by Berlin Questionnaire predicts events in patients with acute coronary syndrome.

Authors:  Eryca Vanessa S de Jesus; Euvaldo B Dias-Filho; Bethania de M Mota; Luiz de Souza; Celi Marques-Santos; João Bosco G Rocha; Joselina L M Oliveira; Antônio C S Sousa; José Augusto Barreto-Filho
Journal:  Arq Bras Cardiol       Date:  2010-08-06       Impact factor: 2.000

2.  Prevalence of sleep apnea syndrome among patients with essential hypertension.

Authors:  P Lavie; R Ben-Yosef; A E Rubin
Journal:  Am Heart J       Date:  1984-08       Impact factor: 4.749

3.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

4.  Association between polysomnographic measures of disrupted sleep and prothrombotic factors.

Authors:  Roland von Känel; José S Loredo; Sonia Ancoli-Israel; Paul J Mills; Loki Natarajan; Joel E Dimsdale
Journal:  Chest       Date:  2007-03       Impact factor: 9.410

5.  Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events.

Authors:  Fred S Apple; Lesly A Pearce; Stephen W Smith; Jason M Kaczmarek; Maryann M Murakami
Journal:  Clin Chem       Date:  2009-03-19       Impact factor: 8.327

6.  Obstructive sleep apnea as a risk factor for type 2 diabetes.

Authors:  Nader Botros; John Concato; Vahid Mohsenin; Bernardo Selim; Kervin Doctor; Henry Klar Yaggi
Journal:  Am J Med       Date:  2009-12       Impact factor: 4.965

7.  Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations.

Authors:  Fred S Apple; Heidi E Quist; Patrick J Doyle; Angela P Otto; MaryAnn M Murakami
Journal:  Clin Chem       Date:  2003-08       Impact factor: 8.327

8.  HDL-cholesterol level provides additional prognosis in acute coronary syndromes.

Authors:  Luís C L Correia; Mário S Rocha; J Péricles Esteves
Journal:  Int J Cardiol       Date:  2008-08-15       Impact factor: 4.164

9.  Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial.

Authors:  James A de Lemos; David A Morrow; Michael A Blazing; Petr Jarolim; Stephen D Wiviott; Marc S Sabatine; Robert M Califf; Eugene Braunwald
Journal:  J Am Coll Cardiol       Date:  2007-11-13       Impact factor: 24.094

10.  Predictors of hospital mortality in the global registry of acute coronary events.

Authors:  Christopher B Granger; Robert J Goldberg; Omar Dabbous; Karen S Pieper; Kim A Eagle; Christopher P Cannon; Frans Van De Werf; Alvaro Avezum; Shaun G Goodman; Marcus D Flather; Keith A A Fox
Journal:  Arch Intern Med       Date:  2003-10-27
View more
  18 in total

1.  Relationship between severity of obstructive sleep apnea and adverse cardiac outcomes in non-diabetic patients presenting with myocardial infarction.

Authors:  Liang-Ping Zhao; Kelvin Loh; Germaine Loo; See-Meng Khoo; Liang Shen; Chi-Hang Lee
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-07       Impact factor: 2.503

2.  ECG-derived Cheyne-Stokes respiration and periodic breathing in healthy and hospitalized populations.

Authors:  Adelita Tinoco; Barbara J Drew; Xiao Hu; David Mortara; Bruce A Cooper; Michele M Pelter
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-06-15       Impact factor: 1.468

Review 3.  The importance of sleep-disordered breathing in cardiovascular disease.

Authors:  Dominik Linz; Holger Woehrle; Thomas Bitter; Henrik Fox; Martin R Cowie; Michael Böhm; Olaf Oldenburg
Journal:  Clin Res Cardiol       Date:  2015-04-23       Impact factor: 5.460

4.  The injury theory, endothelial progenitors, and sleep apnea.

Authors:  Leila Kheirandish-Gozal; Ramon Farré
Journal:  Am J Respir Crit Care Med       Date:  2013-01-01       Impact factor: 21.405

5.  Risk of sleep apnea in hospitalized older patients.

Authors:  Talia C Shear; Jay S Balachandran; Babak Mokhlesi; Lisa M Spampinato; Kristen L Knutson; David O Meltzer; Vineet M Arora
Journal:  J Clin Sleep Med       Date:  2014-10-15       Impact factor: 4.062

Review 6.  Prevalence of sleep-disordered breathing in acute coronary syndrome: a systemic review and meta-analysis.

Authors:  Zhuoshan Huang; Zhengda Zheng; Yanting Luo; Suhua Li; Jieming Zhu; Jinlai Liu
Journal:  Sleep Breath       Date:  2016-08-22       Impact factor: 2.816

7.  Sleep in hospitalized patients with chronic obstructive pulmonary disease: an observational study.

Authors:  Nancy H Stewart; Ryan W Walters; Babak Mokhlesi; Diane S Lauderdale; Vineet M Arora
Journal:  J Clin Sleep Med       Date:  2020-10-15       Impact factor: 4.062

Review 8.  Obstructive sleep apnea, hypertension and cardiovascular diseases.

Authors:  C Gonzaga; A Bertolami; M Bertolami; C Amodeo; D Calhoun
Journal:  J Hum Hypertens       Date:  2015-03-12       Impact factor: 3.012

9.  Rationale and methodology of the impact of continuous positive airway pressure on patients with ACS and nonsleepy OSA: the ISAACC Trial.

Authors:  Cristina Esquinas; Manuel Sánchez-de-la Torre; Albina Aldomá; Marina Florés; Montserrat Martínez; Antonia Barceló; Ferran Barbé
Journal:  Clin Cardiol       Date:  2013-07-10       Impact factor: 2.882

10.  The prevalence and impact of pre-existing sleep disorder diagnoses and objective sleep parameters in patients hospitalized for COVID-19.

Authors:  Cathy A Goldstein; Muneer Rizvydeen; Deirdre A Conroy; Louise M O'Brien; Gita Gupta; Emily C Somers; Pratima Sharma; Jonathan L Golob; Jonathan P Troost; Helen J Burgess
Journal:  J Clin Sleep Med       Date:  2021-05-01       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.